ID: ALA5209265

Max Phase: Preclinical

Molecular Formula: C25H20O3

Molecular Weight: 368.43

Associated Items:

Representations

Canonical SMILES:  CC(=O)C1C(=O)C[C@@H]2CC[C@@]13c1c(cccc12)Oc1ccc2ccccc2c13

Standard InChI:  InChI=1S/C25H20O3/c1-14(26)22-19(27)13-16-11-12-25(22)23-17-6-3-2-5-15(17)9-10-21(23)28-20-8-4-7-18(16)24(20)25/h2-10,16,22H,11-13H2,1H3/t16-,22?,25+/m0/s1

Standard InChI Key:  JYGJLJRMRDMOAB-GKPCJULNSA-N

Associated Targets(Human)

Bel-7402 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MG-63 795 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 368.43Molecular Weight (Monoisotopic): 368.1412AlogP: 5.29#Rotatable Bonds: 1
Polar Surface Area: 43.37Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.05CX Basic pKa: CX LogP: 4.82CX LogD: 4.82
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: 0.73

References

1. Maia M, Resende DISP, Durães F, Pinto MMM, Sousa E..  (2021)  Xanthenes in Medicinal Chemistry - Synthetic strategies and biological activities.,  210  [PMID:33310284] [10.1016/j.ejmech.2020.113085]

Source